Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,759
Closed -$203K 138
2023
Q2
$203K Buy
+1,759
New +$200K 0.05% 127
2023
Q1
Sell
-18,308
Closed -$2.03M 169
2022
Q4
$2.03M Buy
+18,308
New +$1.87M 0.46% 66
2021
Q3
Sell
-1,602
Closed -$125K 212
2021
Q2
$125K Buy
+1,602
New +$119K 0.03% 92
2020
Q4
Sell
-1,681
Closed -$133K 169
2020
Q3
$133K Buy
+1,681
New +$132K 0.05% 69

Other funds holding MRK

Beck Bode LLC's MRK Position: Q3 2023 in Review

Beck Bode LLC sold out of Merck (MRK) in Q3 2023, closing a stake of 1,759 shares — an estimated $203K sold.

Beck Bode LLC first reported a position in MRK in Q3 2020 and held it in 4 quarters. The position peaked at $2.03M in Q4 2022. 3,215 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Beck Bode LLC reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Beck Bode LLC sold 1,759 Merck shares in Q3 2023, an estimated $203K.
  • Beck Bode LLC first reported a position in Merck in Q3 2020 and held it in 4 quarters.
  • Beck Bode LLC's Merck position peaked at $2.03M in Q4 2022.
  • 3,215 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Beck Bode LLC's 13F filing for Q3 2023, filed 2 Nov 2023.